U.S. Markets close in 23 mins

MacroGenics (MGNX) Worth Watching: Stock Up 5.1%

Zacks Equity Research

MacroGenics, Inc. (MGNX) was a big mover last session with its shares rising over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $18.26 to $20.34.

This clinical-stage biopharmaceutical company has seen a mixed track record when it comes to estimate revisions of 3 increases and 1 decrease over the last 30 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

MacroGenics currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the medical industry may consider other well-placed stocks like Cardica Inc. (CRDC), Eagle Pharmaceuticals Inc. (EGRX) and ICU Medical, Inc. (ICUI). All the three stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

MACROGENICS INC (MGNX): Free Stock Analysis Report

CARDICA INC (CRDC): Free Stock Analysis Report


ICU MEDICAL INC (ICUI): Free Stock Analysis Report

Zacks Investment Research